SEARCH FOR ANTI-OBESE AND ANTIDIABETOGENIC PRINCIPLES FROM THE AYURUVEDIC NATURAL MEDICINES
SEARCH FOR ANTI-OBESE AND ANTIDIABETOGENIC PRINCIPLES FROM THE AYURUVEDIC NATURAL MEDICINES
批准号:
14572022
负责人:
YOSHIKAWA Masayuki
金额:
$2.5万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The genus Salacia have been used as a specific remedy at the initial stages of diabetes in the Ayuruvedic system of Indian traditional medicine. The aqueous methanolic extract from the roots and stems of S.reticulata, S.oblonga, and S.chinensis were found to show hypoglycaemic activity in rats and α-glucosidase inhibitory activity. By bioassay-guided separation, salacinol and kotalanol, which having the unique thiosugar sulfonium sulfate inner salt structures, were isolated as the active constituents. Particularly, sucrase and maltase inhibitory activities (in vitro) and inhibitory effects on serum glucose levels in sucrose-and maltose-loaded rats (in vivo) of salacinol were more potent than those of commercial medicine as α-glucosidase inhibitor, acarbose. In addition, the water extract of S.reticulata and its polyphenolic constituents indcuding mangiferin found to show anti-obese activity. Furthermore, seven new triterpenes and two new sesquiterpenes were isolated from the stems of S.chinensis and its triterpene constirutens found to show inhibit aldose reductase inhibitory activity and radical scavenging activities.The methanolic extract from artichoke exhibited anti-hyprelipidemic activity and several sesquiterpenes were isolated as the active components.To clarify structural requirements for aldose reductase, AGEs formation, and radical scavenging activities, various flavonoid compounds were examined above-mentioned screening tests and suggested several structure-activity relationships.
期刊论文(55)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Masayuki Yoshikawa et al.: "Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities"Bioorg.Med.Chem.. 11. 5317-5323 (2003)
Masayuki Yoshikawa 等:“黄酮类化合物抑制蛋白质糖化和自由基清除活性的结构要求”Bioorg.Med.Chem.. 11. 5317-5323 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
吉川 雅之: "薬用食物の糖尿病予防成分 医食同源の視点から"化学と生物. 40. 172-178 (2002)
吉川雅之:“从药食同源的角度看药用食品中的糖尿病预防成分”《化学与生物学》40。172-178(2002)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Masayuki Yoshikawa: "Antidiabetogenic Constituents from Several Natural Medicines"Pure Appl.Chem.. 74. 1301-1308 (2002)
Masayuki Yoshikawa:“来自几种天然药物的抗糖尿病成分”Pure Appl.Chem.. 74. 1301-1308 (2002)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
吉川雅之: "Salacia属植物の抗糖尿病および抗肥満作用成分"FOOD Style 21. 6. 72-78 (2002)
Masayuki Yoshikawa:“五层龙植物的抗糖尿病和抗肥胖活性成分” FOOD Style 21. 6. 72-78 (2002)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Masayuki Yoshikawa et al.: "Absolute stereostructure of potent α-glucosidase inhibitor, salacinol, with unique thiosugar sulfonium sulfate inner salt structure from Salacia reticulata"Bioorg.Med.Chem.. 10. 1547-1554 (2002)
Masayuki Yoshikawa 等人:“强效 α-葡萄糖苷酶抑制剂 Salacinol 的绝对立体结构,具有来自网状五层龙的独特硫代糖硫酸锍内盐结构”Bioorg.Med.Chem.. 10. 1547-1554 (2002)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 21 条
A classification study of Unique Forms and Usages of Chinese Characters
-
批准号:25284076
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.07万
-
财政年份:2013
-
负责人:YOSHIKAWA Masayuki
-
依托单位:
Search for protective compounds from Egyptian traditional medicines on metabolic syndrome
-
批准号:21590031
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2009
-
负责人:YOSHIKAWA Masayuki
-
依托单位:
A general study on the unclassified languages spoken in the southern Hunan province of China
-
批准号:20401020
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.74万
-
财政年份:2008
-
负责人:YOSHIKAWA Masayuki
-
依托单位:
Development for preventive and therapeutic constituents on lifestyle diseases from spices
-
批准号:19590024
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2007
-
负责人:YOSHIKAWA Masayuki
-
依托单位:
SEARCH FOR NEW ANTIDIABETOGENIC AND ANTI-OBESE SEED COMPOUNDS FROM THE TRADITIONAL EGYPTIAN MEDICINES
-
批准号:16590023
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2004
-
负责人:YOSHIKAWA Masayuki
-
依托单位:
A Sociolinguistic Study on the Transition and Variation of Reading and Writing in Hong Kong.
-
批准号:16320048
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$5.7万
-
财政年份:2004
-
负责人:YOSHIKAWA Masayuki
-
依托单位:
Biological Activities of Triterpene Saponins Mediated by Stimulating on Nervous System in Digestive Tract
-
批准号:12672075
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.43万
-
财政年份:2000
-
负责人:YOSHIKAWA Masayuki
-
依托单位:
Characterization of Hepatoprotective Compounds from Chinese Medicinal Herbs with Anti-alcoholic Activity
-
批准号:10672010
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:1998
-
负责人:YOSHIKAWA Masayuki
-
依托单位:
Search for Bioactive Compounds on the Basis of Characterization of Crude Drug Processings
-
批准号:08672461
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.22万
-
财政年份:1996
-
负责人:YOSHIKAWA Masayuki
-
依托单位:
Characterization of Alcohol-Absorption Inhibitors from Chinese Traditional Medicines with Anti-Alcoholic Activity
-
批准号:07557292
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$1.34万
-
财政年份:1995
-
负责人:YOSHIKAWA Masayuki
-
依托单位:
Search for Antiallergic and Antidiabetic Constituents from Oriental Medicinal Foodstuffs
-
批准号:06672126
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1994
-
负责人:YOSHIKAWA Masayuki
-
依托单位:
Syntheses of Carbocyclic Analogs of Nucleoside and Bioactive Pseudo-Sugars from Carbohydrate
-
批准号:01571151
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1989
-
负责人:YOSHIKAWA Masayuki
-
依托单位:
Chemical Studies on Crude Drug Processing
-
批准号:61571001
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1986
-
负责人:YOSHIKAWA Masayuki
-
依托单位:
Establishment of Quality Evaluation Method for Crude Drugs by GC-MS
-
批准号:60870077
-
项目类别:Grant-in-Aid for Developmental Scientific Research
-
资助金额:$3.84万
-
财政年份:1985
-
负责人:YOSHIKAWA Masayuki
-
依托单位: